391 results on '"Görlach, Agnes"'
Search Results
102. NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II
103. Early Determinants of Pulmonary Vascular Remodeling in Animal Models of Complex Congenital Heart Disease
104. Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease
105. Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α
106. The Hypoxia-Inducible Factor-2α Is Stabilized by Oxidative Stress Involving NOX4
107. Receptor Activation of NADPH Oxidases
108. Reciprocal Regulation of Rac1 and PAK-1 by HIF-1α: A Positive-Feedback Loop Promoting Pulmonary Vascular Remodeling
109. Identification of a Survival-independent Metastasis-enhancing Role of Hypoxia-inducible Factor-1α with a Hypoxia-tolerant Tumor Cell Line
110. The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1
111. Heterocyclic indazole derivatives as SGK1 inhibitors, WO2008138448
112. Targeting SGK1 in diabetes
113. Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNFα exposure
114. Phosphodiesterase 2 Mediates Redox-Sensitive Endothelial Cell Proliferation and Angiogenesis by Thrombin via Rac1 and NADPH Oxidase 2
115. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies
116. The cross-talk between NF-κB and HIF-1: further evidence for a significant liaison
117. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: Role of NFκB-dependent hypoxia-inducible factor-1α transcription
118. The ‘PAI-1 paradox’ in vascular remodelling
119. Hypoxia Up-Regulates Hypoxia-Inducible Factor-1α Transcription by Involving Phosphatidylinositol 3-Kinase and Nuclear Factor κB in Pulmonary Artery Smooth Muscle Cells
120. Abstract 152: Urotensin-II Activates Rac-1 And ROS Production In Pulmonary Artery Smooth Muscle Cells Involving GPR14 And Gα I3 Proteins
121. Abstract 602: FoxO3 Mediates Urotensin-II-induced MMP2 Expression In Pulmonary Artery Smooth Muscle Cells
122. Deficiency of manganese superoxide dismutase in hepatocytes disrupts zonated gene expression in mouse liver
123. Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1α and Mediates Its Destabilization in a VHL-Independent Manner
124. Reactive Oxygen Species Activate the HIF-1α Promoter Via a Functional NFκB Site
125. Vascular remodelling processes: Cells, signals and their integration
126. The response to cardiovascular injury: A field of emerging complexity
127. Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?
128. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus
129. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.
130. Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.
131. NOX2 and NOX4 Mediate Proliferative Response in Endothelial Cells
132. The Endoplasmic Reticulum: Folding, Calcium Homeostasis, Signaling, and Redox Control
133. The role of hypoxia inducible factor-1 in cell metabolism – a possible target in cancer therapy
134. The Serum- and Glucocorticoid-Inducible Kinase Sgk-1 Is Involved in Pulmonary Vascular Remodeling
135. Redox Regulation of the Coagulation Cascade
136. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression
137. Control of Adenosine Transport by Hypoxia
138. Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells
139. Atrial Natriuretic Peptide Induces Mitogen-Activated Protein Kinase Phosphatase-1 in Human Endothelial Cells via Rac1 and NAD(P)H Oxidase/Nox2-Activation
140. Thrombin activates the p21-activated kinase in pulmonary artery smooth muscle cells
141. Redox Control of Blood Coagulation
142. Insights into the Redox Control of Blood Coagulation: Role of Vascular NADPH Oxidase-Derived Reactive Oxygen Species in the Thrombogenic Cycle
143. Rac Regulates Thrombin-Induced Tissue Factor Expression in Pulmonary Artery Smooth Muscle Cells Involving the Nuclear Factor-κB Pathway
144. Expression of hypoxia-inducible factors and of vascular endothelial growth factor in infants with congenital cardiac defect
145. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1
146. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases
147. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression
148. NADPH Oxidase Mediates Tissue Factor–Dependent Surface Procoagulant Activity by Thrombin in Human Vascular Smooth Muscle Cells
149. Thrombin Causes Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells
150. Efficient translation of mouse hypoxia-inducible factor-1α under normoxic and hypoxic conditions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.